Cogent Biosciences, Inc.
Developing precision small molecule therapies for cancers, autoimmune, and rare diseases.
COGT | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 275 WYMAN STREET, 2451 WALTHAM
- Website:
- https://www.cogentbio.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Cogent Biosciences, Inc. is a clinical-stage biotechnology company focused on developing precision therapies for genetically defined diseases. The company designs and develops best-in-class, small molecule therapeutics to address the underlying genetic drivers of cancers, autoimmune conditions, and rare diseases. By leveraging validated biology and a rational drug discovery approach, Cogent aims to create novel treatments for patients with significant unmet medical needs, improving upon existing therapies with known limitations. The company's clinical pipeline is led by its investigational therapy, bezuclastinib.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cogent Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cogent Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cogent Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
